AnalystsYaron WerberYaron Werber's Stock Forecasts
AnalystsYaron Werber
Sectors:
Industries:
Analyst Ranking
Top 27%
#1366 out of 5150 analysts
Average Return
+3.96%
Win Rate
54%20 out of 37
Risk vs Reward
Poor
Good
Yaron Werber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beone Medicines LtdONC | +93.13% | $195.45 | $377.47 | 2024-11-13 - 2025-11-12 | Strong Buy |
Exelixis IncEXEL | +78.56% | $21.93 | $39.15 | 2024-05-01 - 2025-04-30 | Strong Buy |
Beone Medicines LtdONC | +72.86% | $144.12 | $249.13 | 2024-04-24 - 2025-04-23 | Strong Buy |
Ascendis Pharma AASND | +67.38% | $119.50 | $200.02 | 2024-09-04 - 2025-09-03 | Strong Buy |
Ascendis Pharma AASND | +61.57% | $126.51 | $204.40 | 2024-11-15 - 2025-11-14 | Strong Buy |
Yaron Werber Analyst Color
Get additional color on Yaron Werber's coverage of popular stocks
Yaron Werber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $75.00 | +107.01% | Maintains | a month ago |
Exelixis IncEXEL | 3 | Strong Buy | $51.00 | +24.76% | Maintains | a month ago |
Argenx SeARGX | 4 | Strong Buy | $1,146.00 | +30.53% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $99.00 | +22.49% | Maintains | a month ago |
Springworks Therapeutics IncSWTX | 1 | Hold | $47.00 | +0.02% | Downgrades | 7 months ago |
Beone Medicines LtdONC | 6 | Strong Buy | $334.00 | +4.68% | Reiterates | 8 months ago |
Ascendis Pharma AASND | 5 | Strong Buy | $153.00 | N/A | Maintains | a year ago |
Biontech SeBNTX | 5 | Hold | $122.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 5 | Strong Buy | $383.00 | N/A | Maintains | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $67.00 | N/A | Maintains | a year ago |
Fibrogen IncFGEN | 1 | Hold | $625.00 | N/A | Maintains | 3 years ago |
Instil Bio IncTIL | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Genmab AGMAB | 1 | Hold | $38.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
2seventy Bio IncTSVT | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Io Biotech IncIOBT | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Roivant Sciences LtdROIV | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Immuneering CorpIMRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nuvation Bio IncNUVB | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $565.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.